1. Biomarker concordance between primary colorectal cancer and its metastases
   D.S. Bhullar et al, 2019, EBioMedicine CrossRef
2. IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
   Renato Morato ZANATTO et al, 2020, ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) CrossRef
3. Pancreatic Metastasis from Gastrointestinal Stromal Tumor of the Stomach: A Case Report
   Nobutoshi Hagiwara et al, 2016, Journal of Nippon Medical School CrossRef
4. Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS
   Michael P. Whyte et al, 2017, Bone CrossRef
5. RAS and RAF mutation status in the selection of patients for anti-EGFR therapy
   Nuria Mulet-Margalef et al, 2016, Colorectal Cancer CrossRef
6. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
   Fanny Grillet et al, 2017, Gut CrossRef
7. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
   Grazia Palomba et al, 2016, Journal of Translational Medicine CrossRef
8. Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
   Caterina Arru et al, 2021, Advances in Therapy CrossRef
9. Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
   Grazia Palomba et al, 2016, Oncology Letters CrossRef
10. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
    Sara S. Fois et al, 2021, International Journal of Molecular Sciences CrossRef
11. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases
    G A Margonis et al, 2018, British Journal of Surgery CrossRef
12. Red Blood Cell Distribution Width (RDW) Correlates to the Anatomical Location of Colorectal Cancer. Implications for Clinical Use
    Alessandro Fancellu et al, 2022, Journal of Gastrointestinal Cancer CrossRef
13. Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases
    Chen Mao et al, 2015, Scientific Reports CrossRef
14. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
    Peter Jo et al, 2020, PLOS ONE CrossRef
15. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases
    Kenji Fujiyoshi et al, 2017, Oncology Reports CrossRef
16. Panitumumab in the treatment of metastatic colorectal cancer, including wild-type RAS, KRAS and NRAS mCRC
    Mark McGregor et al, 2018, Future Oncology CrossRef
17. Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors
    Giuseppe Aprile et al, 2017, Future Oncology CrossRef